687 related articles for article (PubMed ID: 10647607)
1. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
3. Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease.
Takatsu H; Wada H; Maekawa N; Takemura M; Saito K; Fujiwara H
Nucl Med Commun; 2002 Feb; 23(2):161-6. PubMed ID: 11891470
[TBL] [Abstract][Full Text] [Related]
4. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
[TBL] [Abstract][Full Text] [Related]
5. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
6. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].
Satoh A; Serita T; Tsujihata M
Nihon Rinsho; 1997 Jan; 55(1):202-6. PubMed ID: 9014450
[TBL] [Abstract][Full Text] [Related]
7. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
8. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
[TBL] [Abstract][Full Text] [Related]
9. Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease.
Haensch CA; Lerch H; Jörg J; Isenmann S
Parkinsonism Relat Disord; 2009 Feb; 15(2):134-7. PubMed ID: 18515170
[TBL] [Abstract][Full Text] [Related]
10. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
11. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
[TBL] [Abstract][Full Text] [Related]
12. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Rascol O; Schelosky L
Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
[TBL] [Abstract][Full Text] [Related]
13. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of orthostatic hypotension in Parkinson's disease.
Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K
Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498
[TBL] [Abstract][Full Text] [Related]
15. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
16. Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease.
Manabe Y; Fujii D; Kono S; Sakai Y; Tanaka T; Narai H; Omori N; Imai Y; Abe K
J Neurol Sci; 2011 Aug; 307(1-2):153-6. PubMed ID: 21640359
[TBL] [Abstract][Full Text] [Related]
17. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
Reinhardt MJ; Jüngling FD; Krause TM; Braune S
Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
[TBL] [Abstract][Full Text] [Related]
18. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
[TBL] [Abstract][Full Text] [Related]
19. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
Mitsui J; Saito Y; Momose T; Shimizu J; Arai N; Shibahara J; Ugawa Y; Kanazawa I; Tsuji S; Murayama S
J Neurol Sci; 2006 Apr; 243(1-2):101-4. PubMed ID: 16442563
[TBL] [Abstract][Full Text] [Related]
20. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
